| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.39 | 2e-23 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.43 | 8e-17 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.45 | 6e-15 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-14 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.37 | 5e-12 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-08 |